Feedback (FDBK)

Sector:

Health Care

Index:

FTSE AIM All-Share

 110.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 142.50
  • 52 Week Low: 58.00
  • Currency: UK Pounds
  • Shares Issued: 13.33m
  • Volume: 1,561
  • Market Cap: £14.67m
  • RiskGrade: 267

Feedback losses widen despite improved sales

By Iain Gilbert

Date: Wednesday 03 Oct 2018

LONDON (ShareCast) - (Sharecast News) - Medical imaging technology outfit Feedback saw its invoiced sales soar in its last trading year as a result of increased investment in its employees, although the move also resulted in wider full-year losses.
Feedback invoiced sales of £771,000 for the year ended 31 May, a 51% increase year-on-year, but saw recognised revenues slip 1.72% to £458,000.

The AIM-listed firm told investors on Wednesday that costs associated with its recruitment and restructuring had caused its operating loss for the year to widen 150% to £750,000.

However, Feedback assured investors that its investment had already led to a "significant improvement in sales performance and anticipated long-term growth", with sales in the first quarter of its current year up 100% to £236,000.

Executive chairman Alastair Riddell, said: "This has been a year of transition for Feedback into an integrated medical imaging solutions company, with talented staff and an experienced management team."

"As a result of the investment in our employees, we are seeing improved sales momentum throughout the business, demonstrated by the number and size of orders coming through and in the high calibre international distributors we are now working with."

As of 0815 BST, Feedback shares had slid 11.53% to 1.59p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Feedback Market Data

Currency UK Pounds
Share Price 110.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 142.50
52 Week Low 58.00
Volume 1,561
Shares Issued 13.33m
Market Cap £14.67m
RiskGrade 267

Feedback Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
Price Trend
0.4% below the market average0.4% below the market average0.4% below the market average0.4% below the market average0.4% below the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Income Not Available
Growth
49.47% above the market average49.47% above the market average49.47% above the market average49.47% above the market average49.47% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Feedback Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
13:02 1,411 @ 111.00p
12:24 150 @ 105.00p

Feedback Key Personnel

CEO Tom Oakley
CFO Anesh Patel

Top of Page